Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.

Abstract:

BACKGROUND:Several national guidelines recommend continuous use of antipsychotic medication after a psychotic episode in order to minimize the risk of relapse. However some studies have identified a subgroup of patients who obtain remission of psychotic symptoms while not being on antipsychotic medication for a period of time. This study investigated the long-term outcome and characteristics of patients in remission of psychotic symptoms with no use of antipsychotic medication at the 10-year follow-up. METHODS:The study was a cohort study including 496 patients diagnosed with schizophrenia spectrum disorders (ICD 10: F20 and F22-29). Patients were included in the Danish OPUS Trial and followed up 10years after inclusion, where patient data was collected on socio-demographic factors, psychopathology, level of functioning and medication. FINDINGS:61% of the patients from the original cohort attended the 10-year follow up and 30% of these had remission of psychotic symptoms at the time of the 10-year follow up with no current use of antipsychotic medication. This outcome was associated with female gender, high GAF-F score, participation in the labour market and absence of substance abuse. CONCLUSION:Our results describe a subgroup of patients who obtained remission while not being on antipsychotic medication at the 10-year follow-up. The finding calls for further investigation on a more individualized approach to long-term treatment with antipsychotic medication.

journal_name

Schizophr Res

journal_title

Schizophrenia research

authors

Wils RS,Gotfredsen DR,Hjorthøj C,Austin SF,Albert N,Secher RG,Thorup AA,Mors O,Nordentoft M

doi

10.1016/j.schres.2016.10.030

subject

Has Abstract

pub_date

2017-04-01 00:00:00

pages

42-48

eissn

0920-9964

issn

1573-2509

pii

S0920-9964(16)30474-1

journal_volume

182

pub_type

杂志文章
  • Pharmacokinetic-pharmacodynamic modeling of antipsychotic drugs in patients with schizophrenia Part I: the use of PANSS total score and clinical utility.

    abstract:BACKGROUND:To develop a pharmacokinetic-pharmacodynamic (PK-PD) model using individual-level data of Positive and Negative Syndrome Scale (PANSS) total score to characterize the antipsychotic drug effect taking into account the placebo effect and dropout rate. In addition, a clinical utility (CU) criterion that describ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.02.011

    authors: Pilla Reddy V,Kozielska M,Suleiman AA,Johnson M,Vermeulen A,Liu J,de Greef R,Groothuis GM,Danhof M,Proost JH

    更新日期:2013-05-01 00:00:00

  • Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathway.

    abstract::Pro-inflammatory cytokines have been consistently reported to be elevated in schizophrenia patients. However, it is not known whether cytokines influence the presentation of psychotic symptoms. To address this issue, we evaluated the relationship between levels of inflammatory molecules and psychopathological paramete...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.10.019

    authors: Dimitrov DH,Lee S,Yantis J,Valdez C,Paredes RM,Braida N,Velligan D,Walss-Bass C

    更新日期:2013-12-01 00:00:00

  • Studies of individuals with schizophrenia never treated with antipsychotic medications: a review.

    abstract::A review of 65 studies of individuals with schizophrenia who had never been treated with antipsychotic medications indicates significant abnormalities in brain structure and function. Neurological and neuropsychological measures show the most consistent and largest group differences between those affected and normal c...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/s0920-9964(02)00381-x

    authors: Torrey EF

    更新日期:2002-12-01 00:00:00

  • Inverse correlation between hallucinations and serum prolactin in patients with non-affective psychoses.

    abstract::Serum prolactin (PRL) was correlated with clinical symptomatology in 17 drug-free patients suffering from non-affective psychoses. A clear-cut negative correlation was found between the Comprehensive Psychiatric Rating Scale (CPRS) items assessing hallucinations and serum PRL levels (r=-6.14, P=0.009). No correlation ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(99)00195-4

    authors: Appleberg B,Katila H,Rimón R

    更新日期:2000-09-01 00:00:00

  • Risk of schizophrenia and other non-affective psychosis among individuals exposed to head injury: case control study.

    abstract::Studies of the risk of schizophrenia and related non-affective psychoses among individuals exposed to head injury have reported conflicting findings. The diagnostic specificity of reported associations remains unclear and the effects of sex, genetic vulnerability and timing of exposures are also uncertain. The authors...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2006.07.001

    authors: Harrison G,Whitley E,Rasmussen F,Lewis G,Dalman C,Gunnell D

    更新日期:2006-12-01 00:00:00

  • An fMRI investigation of procedural learning in unaffected siblings of individuals with schizophrenia.

    abstract::Vulnerability for schizophrenia is related, in part, to genetic predisposition. The identification of pathophysiological abnormalities associated with the disorder that are also present in unaffected family members of individuals with schizophrenia may assist in delineating the genetic contributions to vulnerability f...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2007.04.026

    authors: Woodward ND,Tibbo P,Purdon SE

    更新日期:2007-08-01 00:00:00

  • Abnormal GABAergic function and face processing in schizophrenia: A pharmacologic-fMRI study.

    abstract::The involvement of the gamma-aminobutyric acid (GABA) system in schizophrenia is suggested by postmortem studies and the common use of GABA receptor-potentiating agents in treatment. In a recent study, we used a benzodiazepine challenge to demonstrate abnormal GABAergic function during processing of negative visual st...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.08.022

    authors: Tso IF,Fang Y,Phan KL,Welsh RC,Taylor SF

    更新日期:2015-10-01 00:00:00

  • Trait or state? A longitudinal neuropsychological evaluation and fMRI study in schizoaffective disorder.

    abstract::Schizoaffective patients can have neurocognitive deficits and default mode network dysfunction while being acutely ill. It remains unclear to what extent these abnormalities persist when they go into clinical remission. Memory and executive function were tested in 22 acutely ill schizoaffective patients; they also und...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2014.08.017

    authors: Madre M,Radua J,Landin-Romero R,Alonso-Lana S,Salvador R,Panicali F,Pomarol-Clotet E,Amann BL

    更新日期:2014-11-01 00:00:00

  • Effect of antipsychotic drugs on gene expression in the prefrontal cortex and nucleus accumbens in the spontaneously hypertensive rat (SHR).

    abstract::Antipsychotic drugs (APDs) are the standard treatment for schizophrenia. The therapeutic effect of these drugs is dependent upon the dopaminergic D2 blockade, but they also modulate other neurotransmitter pathways. The exact mechanisms underlying the clinical response to APDs are not fully understood. In this study, w...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2014.05.015

    authors: Santoro ML,Ota VK,Stilhano RS,Silva PN,Santos CM,Diana MC,Gadelha A,Bressan RA,Melaragno MI,Han SW,Abílio VC,Belangero SI

    更新日期:2014-08-01 00:00:00

  • Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia.

    abstract::Elevated serum levels of Interleukin-3 (IL-3), a major component of the cytokines, have been observed in chronic and medicated patients with schizophrenia, but this elevation may reflect either or both medication and illness chronicity effects. Thus, we compared serum IL-3 levels in first-episode drug-naive (FEDN) to ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2016.05.010

    authors: Fu YY,Zhang T,Xiu MH,Tang W,Han M,Yun LT,Chen DC,Chen S,Tan SP,Soares JC,Tang WJ,Zhang XY

    更新日期:2016-10-01 00:00:00

  • Olfactory deficits in neuroleptic naive patients with schizophrenia.

    abstract::Because previous studies have shown deficits in olfactory identification for male patients with schizophrenia, either withdrawn from or receiving neuroleptic medication, the purpose of the current study was to determine if such deficits occurred in male patients who had never received neuroleptics. A sample of male (n...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(93)90022-b

    authors: Kopala LC,Clark C,Hurwitz T

    更新日期:1993-01-01 00:00:00

  • Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis.

    abstract::Valid criteria to identify young people who are believed to be at ultra high risk (UHR) of developing a psychotic episode were developed over the last decade. The first randomized controlled trial of treatment in a UHR cohort indicated that specific pharmacotherapy and psychotherapy delayed onset of disorder, and poss...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2007.05.018

    authors: Phillips LJ,McGorry PD,Yuen HP,Ward J,Donovan K,Kelly D,Francey SM,Yung AR

    更新日期:2007-11-01 00:00:00

  • Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome.

    abstract::Recently, apolipoprotein D (apoD), a protein that is involved in the essential polyunsaturated fatty acid (EPUFA) transport and metabolism, and neuronal growth and regeneration was reported to have increased in the postmortem brain and decreased in the serum of schizophrenia patients. We studied the plasma apoD levels...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(01)00378-4

    authors: Mahadik SP,Khan MM,Evans DR,Parikh VV

    更新日期:2002-11-01 00:00:00

  • Diagnosis and treatment of psychiatric disorders in children with a schizophrenic parent.

    abstract::Many children of a schizophrenic parent may inherit a portion of the genetic risk factors for schizophrenia. The frequency of DSM-IV psychopathology in children of a schizophrenic parent and the frequency and type of mental health treatment accessed by these youths is not well understood. Twenty-eight adults with schi...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(00)00043-8

    authors: Ross RG,Compagnon N

    更新日期:2001-05-30 00:00:00

  • Effects of the Indianapolis Vocational Intervention Program (IVIP) on defeatist beliefs, work motivation, and work outcomes in serious mental illness.

    abstract::Defeatist beliefs and amotivation are prominent obstacles in vocational rehabilitation for people with serious mental illnesses (SMI). The CBT-based Indianapolis Vocational Intervention Program (IVIP) was specifically designed to reduce defeatist beliefs related to work functioning. In the current study, we examined t...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2016.10.036

    authors: Mervis JE,Fiszdon JM,Lysaker PH,Nienow TM,Mathews L,Wardwell P,Petrik T,Thime W,Choi J

    更新日期:2017-04-01 00:00:00

  • A diffusion tensor imaging family study of the fornix in schizophrenia.

    abstract::Diffusion tensor imaging (DTI) studies suggest abnormalities in the white matter microstructure of the fornix in schizophrenia patients. Research evaluating schizophrenia patient and relatives also suggests that the white matter microstructure of the fornix is heritable. However, previous studies have been hindered by...

    journal_title:Schizophrenia research

    pub_type: 历史文章,杂志文章

    doi:10.1016/j.schres.2014.09.037

    authors: Goghari VM,Billiet T,Sunaert S,Emsell L

    更新日期:2014-11-01 00:00:00

  • Memory and organizational strategies in chronic and acute schizophrenic patients.

    abstract::The memory profile of acute and chronic schizophrenic patients was examined according to the information processing model, with which encoding, retention and retrieval processes of these patients were compared. The effects of an external organizational strategy on their verbal learning and memory were also examined. T...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(99)00078-x

    authors: Chan AS,Kwok IC,Chiu H,Lam L,Pang A,Chow LY

    更新日期:2000-02-14 00:00:00

  • The InterSePT scale for suicidal thinking reliability and validity.

    abstract:BACKGROUND:The InterSePT Scale for Suicidal Thinking (ISST) is a 12-item instrument for the assessment of current suicidal ideation in patients with schizophrenia and schizoaffective disorders. We report the psychometric characteristics of this new scale based on two studies. METHOD:In Study 1, 22 inpatients with schi...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/s0920-9964(02)00335-3

    authors: Lindenmayer JP,Czobor P,Alphs L,Nathan AM,Anand R,Islam Z,Chou JC,InterSePT Study Group.

    更新日期:2003-09-01 00:00:00

  • Hippocampal 5-hydroxytryptamine receptors: abnormalities in postmortem brain from schizophrenic subjects.

    abstract::There is strong evidence that hippocampal 5-hydroxytryptamine (5-HT) systems are affected in schizophrenia and hence we have studied a number of markers of the 5-HT system in hippocampi from subjects with schizophrenia. Using in situ radioligand binding with autoradiography we measured [(3)H]proplyamino-8-hydroxy-1,2,...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2004.02.007

    authors: Scarr E,Pavey G,Copolov D,Dean B

    更新日期:2004-12-01 00:00:00

  • Developmental instability in social anhedonia: an examination of minor physical anomalies and clinical characteristics.

    abstract::Developmental instability (DI) refers to the inability of the developing brain to buffer the effects of genetic and environmental insults. This concept has been invoked to better understand how fetal brain development goes awry in schizophrenia and related spectrum disorders. This study examined one marker of DI, mino...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2009.10.028

    authors: Blanchard JJ,Aghevli M,Wilson A,Sargeant M

    更新日期:2010-05-01 00:00:00

  • Abnormal involuntary movements are linked to psychosis-risk in children and adolescents: Results of a population-based study.

    abstract:BACKGROUND:Altered motor behavior has consistently been reported in medication-naive adult patients with schizophrenia and first episode psychosis and adults at clinical high risk for psychosis (CHR). This study is the first to evaluate the prevalence of abnormal involuntary movements in a community sample of children ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2016.04.032

    authors: Kindler J,Schultze-Lutter F,Michel C,Martz-Irngartinger A,Linder C,Schmidt SJ,Stegmayer K,Schimmelmann BG,Walther S

    更新日期:2016-07-01 00:00:00

  • Subjective wellbeing under quetiapine treatment: effect of diagnosis, mood state, and anxiety.

    abstract:OBJECTIVE:To examine the effect of diagnosis, mood state, and anxiety on subjective wellbeing in patients with affective and non-affective psychotic disorders treated with quetiapine IR. METHODS:2175 patients with schizophrenia-spectrum (SZ, n=1681), schizoaffective (SA, n=249), and bipolar disorder (BPD, n=245) were ...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.schres.2009.03.004

    authors: Lambert M,Naber D,Karow A,Huber CG,Köhler J,Heymann J,Schimmelmann BG

    更新日期:2009-05-01 00:00:00

  • Abnormal white matter microstructure in schizophrenia: a voxelwise analysis of axial and radial diffusivity.

    abstract::Diffusion Tensor Imaging (DTI) investigations in schizophrenia have provided evidence of impairment in white matter as indicated by reduced fractional anisotropy (FA). However, the neuropathological implications of these findings remain unclear. In the current study, we conducted a voxelwise analysis of the constituen...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2007.12.489

    authors: Seal ML,Yücel M,Fornito A,Wood SJ,Harrison BJ,Walterfang M,Pell GS,Pantelis C

    更新日期:2008-04-01 00:00:00

  • Determinants of subjective health-related quality of life (HRQoL) for patients with schizophrenia.

    abstract:PURPOSE:To identify the determinants of schizophrenia-specific HRQoL levels, five types of factors (i.e., sociodemographic, clinical, psychopathological, neurocognitive, and psychosocial factors) were simultaneously investigated in the same cross-sectional sample. METHODS:A total of 120 patients with a diagnosis of sc...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2014.02.011

    authors: Chou CY,Ma MC,Yang TT

    更新日期:2014-04-01 00:00:00

  • MATRICS cognitive consensus battery (MCCB) performance in children, adolescents, and young adults.

    abstract:BACKGROUND:Neurodevelopmental models of schizophrenia suggest that cognitive deficits may be observed during childhood and adolescence, long before the onset of psychotic symptoms. Elucidating the trajectory of normal cognitive development during childhood and adolescence may therefore provide a basis for identifying s...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.11.023

    authors: Nitzburg GC,Derosse P,Burdick KE,Peters BD,Gopin CB,Malhotra AK

    更新日期:2014-01-01 00:00:00

  • The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone.

    abstract:BACKGROUND:A definition of clinical remission in schizophrenia has recently been proposed. However, it is also known that neuropsychological (NP) impairments may be better predictors of functional outcomes than clinical symptoms. Understanding the relationship between clinical remission and cognitive improvement may be...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2006.12.032

    authors: Buckley PF,Harvey PD,Bowie CR,Loebel A

    更新日期:2007-08-01 00:00:00

  • Differential patterns of premorbid social and academic deterioration in deficit and nondeficit schizophrenia.

    abstract::Numerous studies indicate that social dysfunction is associated with negative symptoms of schizophrenia during the chronic phase of illness. However, it is unclear whether social abnormalities exist during the premorbid phase in people who later develop schizophrenia with prominent negative symptoms, or whether social...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2011.11.007

    authors: Strauss GP,Allen DN,Miski P,Buchanan RW,Kirkpatrick B,Carpenter WT Jr

    更新日期:2012-03-01 00:00:00

  • The Arcuate Fasciculus in auditory-verbal hallucinations: a meta-analysis of diffusion-tensor-imaging studies.

    abstract::Auditory-verbal hallucinations (AVHs) are associated with an impaired connectivity of large-scale networks. To examine the relationship between white-matter integrity and AVHs, we conducted a meta-analysis of diffusion-tensor-imaging studies that compared patients with schizophrenia and AVHs with matched healthy contr...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.schres.2014.07.014

    authors: Geoffroy PA,Houenou J,Duhamel A,Amad A,De Weijer AD,Curčić-Blake B,Linden DE,Thomas P,Jardri R

    更新日期:2014-10-01 00:00:00

  • Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia.

    abstract::Glutamate transporters facilitate the buffering, clearance and cycling of glutamate and play an important role in maintaining synaptic and extrasynaptic glutamate levels. Alterations in glutamate transporter expression may lead to abnormal glutamate neurotransmission contributing to the pathophysiology of schizophreni...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.12.019

    authors: Shan D,Lucas EK,Drummond JB,Haroutunian V,Meador-Woodruff JH,McCullumsmith RE

    更新日期:2013-03-01 00:00:00

  • Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: A secondary outcome analysis of the OFFER randomized controlled study.

    abstract::The aim of the study was to assess changes in cortical thickness related to the use of n-3 polyunsaturated fatty acids (PUFA) as add-on therapy in patients with first episode schizophrenia. A double-blind randomized controlled study was conducted using a 26-week intervention composed of concentrated fish oil containin...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2017.10.013

    authors: Pawełczyk T,Piątkowska-Janko E,Bogorodzki P,Gębski P,Grancow-Grabka M,Trafalska E,Żurner N,Pawełczyk A

    更新日期:2018-05-01 00:00:00